Related Experiment Video
Updated: Jun 6, 2026

A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
Published on: December 28, 2013
Quantification of DCE-MRI: pharmacokinetic parameter ratio between TOI and RR in reference region model
1Department of Physics and Astronomy and the BioImaging Research Center (BIRC), the University of Georgia, Athens, GA 30602, USA. azjlee@.uga.edu
Abstract:
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is performed by obtaining sequential MRI images, before, during, and after the injection of a contrast agent. T(1) weighted MR imaging is used to observe the exchange of contrast agent between the vascular space and extravascular extracellular space (EES), providing information about blood volume and microvascular permeability. Signal intensity is obtained from the sequence of T(1) weighted images and then used to estimate the kinetic parameters in the equation derived from the pharmacokinetic model. In a DCE-MRI study, an accurate knowledge of the arterial input function (AIF) is very important to estimate the kinetic parameters. However, the AIF is usually unknown and it remains very difficult to obtain such information noninvasively. Here we use a reference region model that does not require the information about AIF. Though, this model usually needs literature value for the reference region. In this abstract, without knowledge of AIF, K(trans) in the tissue of interest (TOI) is compared with K(trans) in a reference region (RR). This was done by calculating the ratio K(R) between K(trans) in TOI and RR and the ratio V(R) between v(e) in TOI and RR while the K(trans,RR) was assigned a value ranging from 0.1 to 1.0. It is shown from both simulation and in vivo data set that this ratio is independent of K(trans,RR), implying we are no longer required to get the information about literature value for the reference region.
Related Concept Videos
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...
Two-Compartment Open Model: Extravascular Administration
The absorption exponent (ka) indicates the speed at which the drug is...
Quantitative Aspects of Drug-Receptor Interaction
Measurement of Bioavailability: Pharmacodynamic Methods
Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
Three-Compartment Open Model

